About
Medical Imaging Solutions
Hila Pharma is developing products for molecular imaging that will allow precise diagnoses and improved therapy planning. Its main profits come from the field of nuclear medicine, for which the company trades a broad range of products, aimed at both diagnostic and therapeutic purposes.
Hila Pharma is capable of supplying any type of the SPECT range of diagnostic products, PET diagnostic products, MRI contrast agents, and several nuclear therapeutic materials, such as LU-177.
Identity
| Name | Hila Pharma |
|---|---|
| Slug | hila-pharma |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Mm47tsKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | South District |
| HQ city | Nitzan |
| HQ address | HaGefen Street 26, Nizan, Israel |
Web & social
| Website | https://www.alloverunique.com |
|---|
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & DevelopmentIndustrial TechnologiesMaterial Innovations & Applications
Technologies
Materials & SubstancesSimulation & Imaging
Target customers
EducationIndustrial ManufacturingProcess IndustriesCoatingsHealthcare & Life SciencesHealthcareProvidersGovernment & CityTransportation & Logistics
Business models
B2GB2CB2B
Tags
disinfectantsdiagnosticsmedical-devicesradiopharmaceuticalshealthcare-providersbacteriaskin-caremedical-technologiesclean-airgovernmentpublic-transportationsurface-and-coatingsschoolstreatmentsfiltration-and-purificationcancerpeptideshospitals
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}